Latest Articles

By improving sensitivity and boosting signal amplification, nanomaterials are heralding a new era for biomarker detection.

Nine scientists from academia and industry offer their take on the crucial skills tomorrow’s scientists will need to thrive in an evolving research landscape, from AI to digital lab fluency.

GLP-1 drugs like semaglutide and tirzepatide show promise in treating obesity, with benefits including weight loss and improved metabolic health. However, concerns about long-term safety, cost, and accessibility remain.

This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform personalized cancer care.

Spatial transcriptomics is just the start – learn why spatial proteomics is essential to fully understand cell function and disease mechanisms in this thought piece from Dr. Nikhil Rao, CCO at Syncell.

Discover how BILLIE™, the next-generation proteomics platform from MOBILion, enables faster and more accurate quantitation.

Explore how digital biomarkers are transforming clinical trials with real-time data, continuous monitoring and AI-driven patient insights.

Dr. Jennifer Man, director of Science at UK Biocentre, explains why biological sample storage must evolve to prevent costly research losses and meet new regulations with automated, climate-friendly systems.

Metabolomics is expected to increasingly impact precision medicine and diagnostics.

Explore plasma proteomics innovations tackling the dynamic range challenge, revealing biomarkers and advancing personalized medicine with Professor Joshua Coon.